New Generation Low Level Laser Effect in Myofacial Pain Syndrome

NCT ID: NCT06442553

Last Updated: 2024-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-01-15

Study Completion Date

2024-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low level laser treatments have been used to treat painful trigger points in myofascial pain syndrome (MPS), but the effectiveness of the appropriate laser type and parameters is still uncertain. The aim of this study was to compare the effectiveness of different types of low level laser treatment (LLLT) in reducing pain levels, changing oxygen saturation and bite force in patients with MPS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 45 patients with MPS were randomly divided into three groups. First group received LLLT with GRR laser over massater muscle region. Patients in the second group were treated with Nd:YAG laser and the same protocol with Nd:YAG laser was performed in the placebo group using sham device. Pain was evaluated by visual analogue scale (VAS), change in oxygen concentration in the massater muscle was measured by functional near-infrared spectroscopy- fNIRS and bite force was measured with Flexiforce sensors before and after treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myofascial Pain Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GRR laser

patients received 15 sessions GRR laser treatment for 3 weeks

Group Type EXPERIMENTAL

GRR laser

Intervention Type DEVICE

A total of 15 sessions were applied to each patient for three weeks, five times per week.

Nd:YAG Laser

patients received 10 sessions Nd:YAG laser treatment for 2 weeks

Group Type EXPERIMENTAL

Nd:YAG laser

Intervention Type DEVICE

A total of 10 sessions, five sessions per week, were applied

placebo

patients received 10 sessions emission-free laser treatment for 2 weeks

Group Type PLACEBO_COMPARATOR

Nd:YAG laser

Intervention Type DEVICE

A total of 10 sessions, five sessions per week, were applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GRR laser

A total of 15 sessions were applied to each patient for three weeks, five times per week.

Intervention Type DEVICE

Nd:YAG laser

A total of 10 sessions, five sessions per week, were applied

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

-patients with symptoms of temporomandibular disorders and diagnosed with MPS as a result of the clinical examination.

Exclusion Criteria

* Patients with internal TMJ irregularities or degenerative joint changes,
* patients with restricted mouth opening, deviation or deflection,
* patients with systemic diseases,
* pregnant women,
* patients who had received MPS treatment within the previous year
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Gaziantep

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

İREM KARAGOZOGLU

Assist. Prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

İREM KARAGÖZOĞLU

Role: PRINCIPAL_INVESTIGATOR

GAZİANTEP ÜNİVERSİTESİ DİŞ HEKİMLİĞİ FAKÜLTESİ

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İrem Karagözoğlu

Şehitkamil, Gazi̇antep, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Karagozoglu I, Demirkol N, Parlar Oz O, Yilmaz S, Ozcan M. New generation low level laser effect on masseter muscle oxygenation, bite force and algometric changes in myofacial pain syndrome: a randomised, placebo-controlled clinical trial. Lasers Med Sci. 2025 Jan 27;40(1):48. doi: 10.1007/s10103-024-04272-z.

Reference Type DERIVED
PMID: 39869221 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KARAGOZOGLUI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.